Nextbiotix becomes Exeliom Biosciences

#HealthcareInnovation #ClinicalTrial #CDI #Partnership #ExeliomBiosciences #HospicesCivilsdeLyon #MedicalResearch #HealthcareInnovation #ExeliomBiosciences #Biotech #Start-up #Microbiome #Cdiff

Nov 6, 2023

Exeliom Biosciences and Hospices Civils de Lyon announce clinical collaboration in recurrent Clostridioides difficile infection

Explore

#biotech #crohn'sdisease #clinicalstudy #milestones #immunotherapy #microbiome #livebiotherapeutics

Oct 19, 2023

Exeliom Biosciences Announces that the Independent Data Monitoring Committee (IDMC) Recommends Continuation of Phase 1 Clinical Trial of EXL01 in Crohn’s Disease

Explore

Series-A Biotech Exeliom Biosciences Nextbiotix

Jul 5, 2018

Exeliom Biosciences (formerly Nextbiotix) raises €7 million to tackle inflammatory bowel diseases

Explore

Nextbiotix becomes Exeliom Biosciences

contact